Galien Medstartup Award 2017

Published on 11/10/2017

October 25-26, 2017

New York, USA

“Presented by the Galien Foundation and Business France, the Prix Galien – MedStartUp Award encourages and rewards the most promising startups in Healthcare formed through international partnerships between French, Israeli, and North American innovators. The program brings together companies from the pharmaceutical, biotechnology, medical technology and healthcare industries, where innovation, scientific excellence and commercial goals are paramount” (galienfoundation.org)

ENYO Pharma is proud to announce its participation to the 4th Galien Medstartup 2017 program in New York on October 25-26th. The company will present its unique approach regarding drug discovery inspired by viruses. It is a great opportunity for ENYO Pharma to pitch during this event as some major actors in the health industry will be present. This nomination is a significant recognition for the advancement of research carried out over the past few years and perfectly shows ENYO Pharma’s desire to expand its innovation worldwide.

http://medstartup.galienfoundation.org/wp/

Read next in 'Events'

• The 2024 international workshop on Alport syndrome
• ENYO Pharma annonce un financement de Série C de 39 millions d'euros et l’autorisation de la FDA (IND) pour tester Vonafexor dans un essai clinique de Phase 2 pour les patients atteints du syndrome d'Alport
• 6th CKD Summit – Chronic Kidney Disease Drug Development
• ASN Kidney Week
• Alport Connect 2023, the annual Alport syndrome patient and family meeting in US